name: Tumor
id: urn:uuid:bca75647-4ab1-4dc5-9e69-93297405683c

enums:
  PrimaryDiagnosisEnum:
    title: primary_diagnosis
    permissible_values:
      Abdominal desmoid:
      Abdominal fibromatosis:
      Achromic nevus:
      Acidophil adenocarcinoma:
      Acidophil adenoma:
      Acidophil carcinoma:
      Acinar adenocarcinoma:
      Acinar adenoma:
      Acinar carcinoma:
      Acinar cell adenoma:
      Acinar cell carcinoma:
      Acinar cell cystadenocarcinoma:
      Acinar cell tumor:
      Acinic cell adenocarcinoma:
      Acinic cell adenoma:
      Acinic cell tumor:
      Acoustic neuroma:
      Acquired cystic disease-associated renal cell carcinoma (RCC):
      Acquired tufted hemangioma:
      Acral lentiginous melanoma, malignant:
      ACTH-producing tumor:
      Acute basophilic leukaemia:
      Acute bilineal leukemia:
      Acute biphenotypic leukemia:
      Acute erythremia:
      Acute erythremic myelosis:
      Acute erythroid leukaemia:
      Acute granulocytic leukemia:
      Acute leukemia, Burkitt range: 
      Acute leukemia, NOS:
      Acute lymphatic leukemia:
      Acute lymphoblastic leukemia-lymphoma, NOS:
      Acute lymphoblastic leukemia, L2 type, NOS:
      Acute lymphoblastic leukemia, mature B-cell range: 
      Acute lymphoblastic leukemia, NOS:
      Acute lymphoblastic leukemia, precursor cell range: 
      Acute lymphocytic leukemia:
      Acute lymphoid leukemia:
      Acute megakaryoblastic leukaemia:
      Acute mixed lineage leukemia:
      Acute monoblastic and monocytic leukemia:
      Acute monoblastic leukemia:
      Acute monocytic leukemia:
      Acute myeloblastic leukemia:
      Acute myelocytic leukemia:
      Acute myelofibrosis:
      Acute myelogenous leukemia:
      Acute myeloid leukaemia, t(8;21)(q22;q22):
      Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1:
      Acute myeloid leukemia with abnormal marrow eosinophils (includes all variants):
      Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1:
      Acute myeloid leukemia with maturation:
      Acute myeloid leukemia with multilineage dysplasia:
      Acute myeloid leukemia with mutated CEBPA:
      Acute myeloid leukemia with mutated NPM1:
      Acute myeloid leukemia with myelodysplasia-related changes:
      Acute myeloid leukemia with prior myelodysplastic syndrome:
      Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214:
      Acute myeloid leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1:
      Acute myeloid leukemia with t(9;11)(p22;q23); MLLT3-MLL:
      Acute myeloid leukemia without maturation:
      Acute myeloid leukemia without prior myelodysplastic syndrome:
      Acute myeloid leukemia, AML1(CBF-alpha)/ETO:
      Acute myeloid leukemia, CBF-beta/MYH11:
      Acute myeloid leukemia, inv(16)(p13;q22):
      Acute myeloid leukemia, M6 range: 
      Acute myeloid leukemia, minimal differentiation:
      Acute myeloid leukemia, MLL:
      Acute myeloid leukemia, NOS:
      Acute myeloid leukemia, PML/RAR-alpha:
      Acute myeloid leukemia, t(15:17)(g22;q11-12):
      Acute myeloid leukemia, t(16;16)(p 13;q 11):
      Acute myelomonocytic leukemia:
      Acute myelomonocytic leukemia with abnormal eosinophils:
      Acute myelosclerosis, NOS:
      Acute myloid leukemia, 11q23 abnormalities:
      Acute non-lymphocytic leukemia:
      Acute panmyelosis with myelofibrosis:
      Acute panmyelosis, NOS:
      Acute progressive histiocytosis X:
      Acute promyelocytic leukaemia, PML-RAR-alpha:
      Acute promyelocytic leukaemia, t(15;17)(q22;q11-12):
      Acute promyelocytic leukemia, NOS:
      Adamantinoma of long bones:
      Adamantinoma, malignant:
      Adamantinoma, NOS:
      Adenoacanthoma:
      Adenoameloblastoma:
      Adenocarcinoid tumor:
      Adenocarcinoma admixed with neuroendocrine carcinoma:
      Adenocarcinoma combined with other types of carcinoma:
      Adenocarcinoma in a polyp, NOS:
      Adenocarcinoma in adenomatous polyp:
      Adenocarcinoma in adenomatous polyposis coli:
      Adenocarcinoma in multiple adenomatous polyps:
      Adenocarcinoma in polypoid adenoma:
      Adenocarcinoma in situ in a polyp, NOS:
      Adenocarcinoma in situ in adenomatous polyp:
      Adenocarcinoma in situ in polypoid adenoma:
      Adenocarcinoma in situ in tubular adenoma:
      Adenocarcinoma in situ in tubulovillous adenoma:
      Adenocarcinoma in situ in villous adenoma:
      Adenocarcinoma in situ, mucinous:
      Adenocarcinoma in situ, non-mucinous:
      Adenocarcinoma in situ, NOS:
      Adenocarcinoma in tubolovillous adenoma:
      Adenocarcinoma in tubular adenoma:
      Adenocarcinoma in villous adenoma:
      Adenocarcinoma of anal ducts:
      Adenocarcinoma of anal glands:
      Adenocarcinoma of rete ovarii:
      Adenocarcinoma with apocrine metaplasia:
      Adenocarcinoma with cartilaginous and osseous metaplasia:
      Adenocarcinoma with cartilaginous metaplasia:
      Adenocarcinoma with mixed subtypes:
      Adenocarcinoma with neuroendocrine differentiation:
      Adenocarcinoma with osseous metaplasia:
      Adenocarcinoma with spindle cell metaplasia:
      Adenocarcinoma with squamous metaplasia:
      Adenocarcinoma, cribriform comedo-range: 
      Adenocarcinoma, cylindroid:
      Adenocarcinoma, diffuse range: 
      Adenocarcinoma, endocervical range: 
      Adenocarcinoma, intestinal range: 
      Adenocarcinoma, metastatic, NOS:
      Adenocarcinoma, NOS:
      Adenocarcinoma, pancreatobiliary range: 
      Adenocystic carcinoma:
      Adenofibroma, NOS:
      Adenoid basal carcinoma:
      Adenoid cystic carcinoma:
      Adenolipoma:
      Adenolymphoma:
      Adenoma of nipple:
      Adenoma, NOS:
      Adenomatoid odontogenic tumor:
      Adenomatoid tumor, NOS:
      Adenomatosis, NOS:
  
  TumorGradeEnum:
    title: tumor_grade
    permissible_values:
      G1:
      G2:
      G3:
      G4:
      GX:
      GB:
      High Grade:
      Intermediate Grade:
      Low Grade:
      Unknown:
      Not Reported:

  TumorStageClinicalTEnum:
    title: tumor_stage_clinical_t
    permissible_values:
      T0:
        description: No evidence of primary tumor
      T1:
      T1a:
      T1a1:
      T1a2:
      T1b:
      T1b1:
      T1b2:
      T1c:
      T1mi:
      T2:
      T2a:
      T2a1:
      T2a2:
      T2b:
      T2c:
      T2d:
      T3:
      T3a:
      T3b:
      T3c:
      T3d:
      T4:
      T4a:
      T4b:
      T4c:
      T4d:
      T4e:
      TX:
        description: Primary tumor cannot be evaluated
      Ta:
      Tis:
      Tis (DCIS):
        description: Carcinoma in situ (early cancer that has not spread to neighboring tissue)
      Tis (LCIS):
      Tis (Paget's):
      Unknown:
      Not Reported:

  TumorStageClinicalNEnum:
    title: tumor_stage_clinical_n
    permissible_values:
      N0:
        description: No regional lymph node involvement (no cancer found in the lymph nodes)
      N0 (i+):
      N0 (i-):
      N0 (mol+):
      N0 (mol-):
      N1:
      N1a:
      N1b:
      N1bI:
      N1bII:
      N1bIII:
      N1bIV:
      N1c:
      N1mi:
      N2:
      N2a:
      N2b:
      N2c:
      N3:
      N3a:
      N3b:
      N3c:
      N4:
      NX:
        description: Regional lymph nodes cannot be evaluated
      Unknown:
      Not Reported:

  TumorStageClinicalMEnum:
    title: tumor_stage_clinical_m
    permissible_values:
      M0:
      M1:
      M1a:
      M1b:
      M1c:
      MX:
      cM0 (i+):
      Unknown:
      Not Reported:

  ProgressionOrRecurrenceEnum:
    title: progression_or_recurrence
    permissible_values:
      yes:
      no:
      unknown:
      not reported:
      Not Allowed To Collect:

  LastKnownDiseaseStatusEnum:
    title: last_known_disease_status
    permissible_values:
      Distant met recurrence/progression:
      Loco-regional recurrence/progression:
      Biochemical evidence of disease without structural correlate:
      Tumor free:

  TumorTissueTypeEnum:
    title: tumor_tissue_type
    permissible_values:
      Additional Primary:
      Atypia or hyperplasia:
      Local recurrence:
      Metastatic:
      Normal:
      Normal adjacent:
      Normal distant:
      NOS:
      Not applicable:
      Not reported:
      Premalignant:
      Premalignant - in situ:
      Primary:
      Recurrent:
      Tissue:
      Tumor post-adjuvant therapy:
      Tumor post-neoadjuvant therapy:
      Tumor post-therapy:
      Tumor specimen from de novo untreated malignancy of the bladder:
      Unknown:
      Xenograft:

  SampleTumorStatusEnum:
    title: sample_tumor_status
    permissible_values:
      Tumor:
      Normal:
      Abnormal:
      Peritumoral:
      Unknown:

  NormalOrTumorSamplePathologyEnum:
    title: normal_or_tumor_sample_pathology
    permissible_values:
      Metastatic Neoplasm:
      Not Applicable:
      Not Otherwise Specified:
      Not Reported:
      Premalignant Neoplasm:
      Primary Neoplasm:
      Recurrent Neoplasm:
      Unknown:
      Xenograft:

# MorphologyEnum:
#   title: morphology
#   permissible_values: 






